Santo Costa

Santo Costa

Direktor/Vorstandsmitglied bei CYTOKINETICS, INCORPORATED

Vermögen: 1 Mio $ am 30.04.2024

78 Jahre
Health Technology
Commercial Services
Technology Services

Profil

Santo J.
Costa
is currently the Chairman at Aquestive Therapeutics, Inc. and the Chairman at The North Carolina Biotechnology Center.
He is also an Independent Director at Cytokinetics, Inc., a Director at Holzworth Holdings, Inc., and Of Counsel at Smith, Anderson, Blount, Dorsett, Mitchell & Jernigan LLP.
Additionally, he is a Member at Fortsum Business Solutions, Inc., a Member at The North Carolina Bar Association, and a Trustee at Ravenscroft School, Inc. In the past, Mr. Costa served as the Vice Chairman, President & Chief Operating Officer at Quintiles Transnational Corp.
from 1994 to 2001.
He was also the Non-Executive Chairman at ArgoMed, Inc. in 2002 and the Chairman at Labopharm, Inc. from 2006 to 2011.
Furthermore, he held the position of Non-Executive Chairman at The Sustainable Nutrition Group Pty Ltd.
from 2014 to 2015 and Chairman at Metabolon, Inc. from 2013 to 2019.
He has also been involved as Chairman at BioPheresis Technologies, Inc. and as a Director at Bausch Health Americas, Inc., OSI Pharmaceuticals, Inc., NPS Pharmaceuticals, Inc., CV Therapeutics, Inc., NeuroMedix, Inc., Biovest Corp.
I, DigiScript, Inc., Magor Corp., Maupin Taylor PA, Williams Mullen PC, Glaxo, Inc., Merrell Dow Pharmaceuticals, Inc., and Norwich Eaton Pharmaceuticals, Inc.Mr. Costa completed his undergraduate and graduate degrees at St. John's University in 1968 and 1971, respectively.

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
15.05.2024 20 600 ( 0,02% ) 1 Mio $ 30.04.2024
22.03.2024 17 327 ( 0,02% ) 68 095 $ 30.04.2024

Aktive Positionen von Santo Costa

UnternehmenPositionBeginn
CYTOKINETICS, INCORPORATED Direktor/Vorstandsmitglied 01.10.2010
AQUESTIVE THERAPEUTICS, INC. Direktor/Vorstandsmitglied 01.04.2024
Direktor/Vorstandsmitglied 01.07.2012
Corporate Officer/Principal -
Corporate Officer/Principal 24.11.2010
Corporate Officer/Principal 01.08.2007
Direktor/Vorstandsmitglied -
Vorsitzender -
Alle aktiven Positionen von Santo Costa

Ehemalige bekannte Positionen von Santo Costa

UnternehmenPositionEnde
Direktor/Vorstandsmitglied 01.05.2019
░░░ ░░░░░░░░░░░ ░░░░░░░░░ ░░░░░ ░░░ ░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░ ░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░ ░░░░░░░░░░
Sehen Sie sich die Erfahrung von Santo Costa im Detail an

Ausbildung von Santo Costa

St. John's University Graduate Degree

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Santo Costa im Detail an

Beziehungen

100 +

Beziehungen ersten Grades

28

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen2
CYTOKINETICS, INCORPORATED

Health Technology

AQUESTIVE THERAPEUTICS, INC.

Health Technology

Private Unternehmen25

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Process Industries

Technology Services

Health Technology

Finance

Commercial Services

Maupin Taylor PA

Commercial Services

Commercial Services

Commercial Services

Technology Services

Commercial Services

Technology Services

Commercial Services

Glaxo, Inc.

Health Technology

Merrell Dow Pharmaceuticals, Inc.

Norwich Eaton Pharmaceuticals, Inc.

Consumer Services

Technology Services

Sehen Sie sich die Unternehmensverbindungen an
  1. Börse
  2. Insiders
  3. Santo Costa